Skip to the main content

Acta Pharmaceutica, Vol. 69 No. 2, 2019.

Review article

https://doi.org/10.2478/acph-2019-0013

Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents

OLAYINKA O. AJANI orcid id orcid.org/0000-0002-3422-3478 ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
MARTINS T. NLEBEMUO ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
JOSEPH A. ADEKOYA ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
KEHINDE O. OGUNNIRAN ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
TOLUTOPE O. SIYANBOLA ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
CHRISTIANA O. AJANAKU ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria

Full text: english pdf 1.142 Kb

page 177-196

downloads: 734

cite

Abstract

Surpassing heart diseases, cancer is taking the lead as the deadliest disease because of its fast rate of spreading in all parts of the world. Tireless commitment to searching for novel therapeutic medicines is a worthwhile adventure in synthetic chemistry because of the drug resistance predicament and regular outbreak of new diseases due to abnormal cell growth and proliferation. Medicinal chemistry researchers and pharmacists have unveiled quinoxaline templates as precursors of importance and valuable intermediates in drug discovery because they have been established to possess diverse pharmacological potentials. Hence, this review highlights the current versatile routes to accessing functionalized quinoxaline motifs and harnessing their documented therapeutic potentials for anticancer drug development.

Keywords

quinoxaline; anticancer activity; pharmacophore

Hrčak ID:

217779

URI

https://hrcak.srce.hr/217779

Publication date:

30.6.2019.

Visits: 1.892 *